Loading transcript...
Click for full transcript
Chapters & Sections (88)
▼
0:00
COVID-19 Vaccine Necessity for Young People
2:12
COVID-19 Delta Variant Affects Younger Population
3:33
COVID-19 Hospitalization Rate Concerns
5:18
US Healthcare System Overwhelmed by Infections
6:45
Vaccine Safety and Side Effects Discussion
9:58
COVID-19 Variants and Long-Haul Syndrome
11:57
COVID-19 Long-Term Brain Damage Effects
14:59
COVID-19 Comorbidity and Stroke Risks
19:57
COVID-19 Vaccine Safety and Spike Protein
22:06
Vaccine Design and Spike Protein Conformation
23:41
Comparing Spike Proteins in Vaccines and SARS-CoV-2
25:59
Spike Protein Safety and COVID-19 Vaccine Concerns
28:36
mRNA Vaccine Safety and Mechanism Explained
30:40
mRNA Vaccine Safety and Distribution Concerns
33:33
Vaccine Safety and Spike Protein Concerns
35:21
COVID-19 Vaccine Safety and Adverse Events
38:45
Vaccine Safety and Adverse Event Reporting
41:02
Vaccine Safety Reporting System Analysis
42:32
COVID-19 Vaccine Reporting and Adverse Events
44:51
Vaccine Safety and Underreporting Concerns
46:28
Vaccine Safety and Reporting Patterns
48:17
Analyzing VAERS Data for Confounding Factors
51:20
COVID-19 Vaccine Safety Compared to COVID-19
52:37
Vaccine Safety and Reporting System Explained
54:21
Vaccine Safety and Conspiracy Theories
56:05
Medical Decisions and Risk vs Benefit
57:46
Vaccine Risks and Benefits Discussion
1:01:16
Antibody-Dependent Enhancement Explained
1:03:33
RSV Vaccine Clinical Trial Failure
1:05:01
Benefits of Pre-Fusion Viral Protein Vaccines
1:06:30
Antibody-Dependent Enhancement Concerns in Vaccines
1:09:45
Pregnancy Outcomes in COVID-19 Vaccine Trials
1:11:48
COVID-19 Vaccine Safety in Pregnancy
1:14:12
mRNA Vaccine Technology and DNA Alteration
1:15:58
mRNA cannot alter human DNA
1:17:33
mRNA Vaccines and DNA Changes Debunked
1:20:10
Swiss Cheese Model of Risk Management
1:22:08
Ivermectin's Effectiveness in Treating COVID-19
1:24:04
Ivermectin's Effectiveness in COVID-19 Treatment
1:27:49
Evaluating Ivermectin as COVID-19 Therapeutic
1:31:59
Ivermectin Study Limitations and Meta-Analysis
1:33:33
Ivermectin's Effectiveness in Viral Clearance
1:35:11
Ivermectin's Efficacy and Safety Concerns
1:36:48
Risks of Ivermectin Use for COVID-19
1:38:36
Ivermectin Studies Lack Randomized Controlled Trials
1:41:08
COVID-19 Vaccination and Lifestyle Optimization
1:42:58
Transmission of SARS-CoV-2 Virus Explained
1:45:11
Vaccine Efficacy Against COVID-19 Variants
1:48:18
Vaccine Efficacy in Preventing Transmission
1:50:21
Vaccine Effectiveness in Preventing Breakthrough Infections
1:52:46
Vaccinated Individuals Shed Less Infectious Virus
1:54:16
Vaccinated People Not Causing Outbreaks
1:55:59
Vaccine Effect on SARS-CoV-2 Virus Evolution
1:58:04
Virus Evolution and Transmission Dynamics
2:00:10
COVID-19 Transmission and Mutation Concerns
2:02:00
Vaccine Effectiveness and Viral Mutation
2:03:25
Viral Variants and Vaccine Effectiveness
2:05:51
Vaccine Efficacy and Resistance to Viruses
2:08:27
Vaccine Development Process and Acceleration
2:10:29
Government Support for Vaccine Development
2:12:04
US Infrastructure Mobilization for War and Vaccine
2:13:42
mRNA Vaccine Development and History
2:15:30
History of mRNA Technology in Humans
2:17:59
mRNA Technology for Solid Tumors Treatment
2:19:39
Vaccine Effectiveness Against Delta Variant